Trailing-twelve-month (TTM) revenue is $153.37 Million with a year-over-year growth of +10.79%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $33,424,703 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q4 FY2025Period ended 2025-12-31 | $56,075,337 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-24 |
| Q1 FY2026Period ended 2026-03-31 | $29,930,342 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-12 |
| Q2 FY2026Period ended 2026-06-30 | $33,944,191 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-11 |
| TTM revenue | $153,374,573 |
Current P/S: $61,585,808 market capitalization ÷ $153,374,573 TTM revenue = 0.40x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $33.94M.
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 22 comparable quarters.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:41:54.677Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Americas | N/A | $147M |
| International | N/A | $7M |
| Other | $930,191 | $841,029 |
$153.37M
$153.37 Million
+10.79%
vs. $138.44M a year ago (TTM)
+25.75%
5 Year compound annual growth rate
1 Year
+10.79%
3 Year
+10.96%
5 Year
+25.75%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $142.44M | +$4.19M | +3.03% |
| 2024 | $138.25M | +$6.13M | +4.64% |
| 2023 | $132.12M | +$36.19M | +37.73% |
| 2022 | $95.93M | +$33.14M | +52.77% |
| 2021 | $62.79M | +$24.14M | +62.44% |
| 2020 |
TTM Growth
+10.79%
3-Year CAGR
+10.96%
5-Year CAGR
+25.75%
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:41:54.677Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $38.66M |
| +$12.09M |
| +45.51% |
